Evidence map›Paper›PMID 33196496›Full record

ArticleAIDS (London, England)2020

Advanced HIV disease during the 'Treat All' era in Botswana.

Michael J Vinikoor, Lottie Hachaambwa

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Michael J VinikoorDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Lottie HachaambwaCenter for International Health, Education, and Biosecurity.

Funding

Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV CoinfectionR01AI147727 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael Jeffrey Vinikoor · 2019 to 2026
$3.9M
Feasibility of an integrated intervention to reduce advanced HIV disease mortality among hospitalized adults in ZambiaR34MH121103 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI VINIKOOR, MICHAEL JEFFREY · 2019 to 2023
$726k
Re-engagement at Discharge (Re-Charge): Improving post-hospital outcomes for HIV-infected adults in ZambiaR34MH122265 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CLAASSEN, CASSIDY W., VINIKOOR, MICHAEL JEFFREY · 2021 to 2023
$594k
NIAID NIH HHS R01 AI147727NIMH NIH HHS R34 MH121103NIMH NIH HHS R34 MH122265
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsBotswanaHumansPrevalenceRisk Factors

Identifiers

PMID33196496
PMCPMC8137811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.